Six hundred intravenous drug users (IVDUs) and two hundred North Africans were screened
for human T‐cell leukemia virus (HTLV) antibodies using several serological methods …

Sera of 1023 subjects belonging to categories at risk for AIDS, positive for HIV-1, were tested
for antibodies to human T-cell leukemia virus (HTLV-1) by ELISA, Western blotting, and …

Abstract Antibodies to HTLV-I/II were inmtigated in sera from 7521 individuals living in
Spain. They were clasified in four major groups: a) subjects at high risk of retroviral …

Conclusions Antibodies to HIV-1, HIV-2, HTLV-I and HTLV-II were detected in 2.76, 0, 0.23
and 0.08% of patients, respectively. The residual risk of HIV-1 infection through blood …

Summary In 1984 10,281 sera were collected in the FRG and examined for antibodies to
HTLV-III (LAV) with an enzyme-linked immunosorbent assay and confirmative tests. Of the …

The human T-lymphotropic virus type I (HTLV-I) has been reported to have an étio logie role
in the pathogenesis of adult T-cell leukemia/lymphoma and a chronic degener ative …

Antibody to HTLV‐I/II was detected in 19 (0.3%) of 6286 plasma donors from five regions of
the United States (US). This seroprevalence rate is approximately 10 times that in whole …

BACKGROUND: Mashhad, in the northeast of Iran has been suggested as an endemic area
for human T cell lymphotropic virus type I (HTLV-I) infection since 1996. OBJECTIVES: We …

To understand the origin and past dissemination of human T‐cell leukemia/lymphotropic
virus type I (HTLV‐I) in Latin America, we conducted a phylogenetic study of five new HTLV …

Sera from 298 HIV-infected individuals from Southern Norway were examined for antibodies
against HTLV. 30 sera (10.1%) were HTLV-II positive and 1 (0.3%) HTLV-I positive. 25 of the …